Hypertension: effective treatment coverage (controlled hypertension) in EUR
EUR: Hypertension: effective treatment coverage (controlled hypertension) was 27.3% in 2019. ◆ Volatile
Hypertension: effective treatment coverage (controlled hypertension) in EUR, 1990–2019
Source: World Health Organization, Global Health Observatory.
Analysis
In 2019, hypertension: effective treatment coverage (controlled hypertension) in EUR stood at 27.3%. That is the highest value across all 30 years on record.
That represents a change of up 2.2% on the previous year and up 38.6% over ten years.
Over the whole period, hypertension: effective treatment coverage (controlled hypertension) in EUR peaked at 27.3% in 2019 and was at its lowest, 4.6%, in 1990.
The series is highly variable year to year, so single readings are best treated with caution.
Hypertension: effective treatment coverage (controlled hypertension) in EUR, year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 4.6% | — |
| 1991 | 4.8% | +4.3% |
| 1992 | 5.1% | +6.2% |
| 1993 | 5.5% | +7.8% |
| 1994 | 5.9% | +7.3% |
| 1995 | 6.5% | +10.2% |
| 1996 | 7.1% | +9.2% |
| 1997 | 7.7% | +8.5% |
| 1998 | 8.4% | +9.1% |
| 1999 | 9.2% | +9.5% |
| 2000 | 10.0% | +8.7% |
| 2001 | 10.9% | +9.0% |
| 2002 | 11.9% | +9.2% |
| 2003 | 12.9% | +8.4% |
| 2004 | 14.0% | +8.5% |
| 2005 | 15.2% | +8.6% |
| 2006 | 16.4% | +7.9% |
| 2007 | 17.5% | +6.7% |
| 2008 | 18.6% | +6.3% |
| 2009 | 19.7% | +5.9% |
| 2010 | 20.7% | +5.1% |
| 2011 | 21.7% | +4.8% |
| 2012 | 22.6% | +4.1% |
| 2013 | 23.4% | +3.5% |
| 2014 | 24.1% | +3.0% |
| 2015 | 24.8% | +2.9% |
| 2016 | 25.4% | +2.4% |
| 2017 | 26.0% | +2.4% |
| 2018 | 26.7% | +2.7% |
| 2019 | 27.3% | +2.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 6.5% | 4.6% | 9.2% | 10 |
| 2000s | 14.7% | 10.0% | 19.7% | 10 |
| 2010s | 24.3% | 20.7% | 27.3% | 10 |
Countries ranked near EUR
- 1 Canada 62.4% compare
- 2 South Korea 55.4% compare
- 3 Iceland 52.6% compare
- 4 Costa Rica 50.3% compare
- 5 United States 49.0% compare
- 6 Germany 47.4% compare
- 6 Portugal 47.4% compare
More health data for EUR
- Pertussis - number of reported cases 52,021 (2025)
- Total tetanus - number of reported cases 85 (2025)
- Infant mortality rate (probability of dying between birth and age 1) 6.52 (2024)
- Under-five mortality rate 7.7 (2024)
- Maternal mortality ratio 11.16 (2023)
- Mortality rate among children ages 5 to 9 years 0.7826 (2024)
- Number of deaths among children ages 5 to 9 years 8,827 (2024)
- Number of deaths among adolescents 10,454 (2024)
- Proportion of population with primary reliance on polluting fuels and 7.6% (2023)
- Population with primary reliance on polluting fuels and technologies 18.78 (2023)
Frequently asked questions
- What is hypertension: effective treatment coverage (controlled hypertension) in EUR?
- Hypertension: effective treatment coverage (controlled hypertension) in EUR was 27.3% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest hypertension: effective treatment coverage (controlled hypertension) recorded in EUR?
- The highest recorded value was 27.3% in 2019.
- What is the lowest hypertension: effective treatment coverage (controlled hypertension) recorded in EUR?
- The lowest recorded value was 4.6% in 1990.
- How does EUR rank for hypertension: effective treatment coverage (controlled hypertension)?
- EUR ranks 4th out of 17 groups with data for 2019.
- Is hypertension: effective treatment coverage (controlled hypertension) rising or falling in EUR?
- Over the last ten years it is up 38.6%. The long-run trend across the full record is volatile.
- Where does this EUR data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).